Michèle Cavo

69.0k citations

557 papers · 14.5k indexed · 4 hit papers · h-index 62

Impact in

Hematology top 0.01%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Oncology top 0.2%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology

Papers in

Hematology 441
- Multiple Myeloma Research and Treatments 361
- Acute Myeloid Leukemia Research 54
- Chronic Myeloid Leukemia Treatments 48
Genetics 135
- Myeloproliferative Neoplasms: Diagnosis and Treatment 65
- Chronic Lymphocytic Leukemia Research 65

Co-authors: Elena Zamagni S Tura Jesús F. San Miguel Paola Tacchetti Michele Baccarani Philippe Moreau Patrizia Tosi Pieter Sonneveld
Journals: Blood (134 papers)Journal of Clinical Oncology (42 papers)European Journal Of Haematology (18 papers)British Journal of Haematology (16 papers)Leukemia (14 papers)
Partner nations: Italy United States Spain

In The Last Decade

Michèle Cavo

525 papers receiving 14.2k citations

Hit Papers

align trajectories log scale

Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† 2021 · 460 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 Annals of Oncology
2020 The Lancet Oncology
2017 Annals of Oncology
2013 Leukemia

Peers

Countries citing papers authored by Michèle Cavo

Since Specialization

Citations

This map shows the geographic impact of Michèle Cavo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michèle Cavo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michèle Cavo more than expected).

Fields of papers citing papers by Michèle Cavo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michèle Cavo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michèle Cavo. The network helps show where Michèle Cavo may publish in the future.

Co-authors

The 25 scholars most cited alongside Michèle Cavo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michèle Cavo Line = papers co-authored together Michèle Cavo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma Cancers ·Katia Mancuso, Simona Barbato, Francesco Di Raimondo, Francesca Gay, Pellegrino Musto, Massimo Offidani, Maria Teresa Petrucci, Elena Zamagni, Renato Zambello, Michèle Cavo	2025	0
2	Noncanonical NF-κB signaling in dendritic cells is required for ATP-driven indoleamine 2,3-dioxygenase 1 induction through P2Y11 receptor Journal of Leukocyte Biology ·Darina Očadlíková, Benedetta Fiordi, Sara Trabanelli, Valentina Salvestrini, Marilena Ciciarello, Dorian Forte, Emma Campazzi, Letizia Vitali, Serenella C Cipollitta, Anna Pegoraro, Camilla Jandus, Francesco Di Virgilio, Elena Adinolfi, Michèle Cavo, Antonio Curti	2025	1
3	Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow‐up subgroup analysis of the BOSTON trial European Journal Of Haematology ·María‐Victoria Mateos, Monika Engelhardt, Xavier Leleu, Mercedes Gironella, Michèle Cavo, Meletios Α. Dimopoulos, Martina Bianco, G Merlo, Charles la Porte, Paul G. Richardson, Philippe Moreau	2024	2
4	A Multiparameter Prognostic Risk Score of Chronic Graft-versus-Host Disease Based on CXCL10 and Plasmacytoid Dendritic Cell Levels in the Peripheral Blood at 3 Months after Allogeneic Hematopoietic Stem Cell Transplantation Transplantation and Cellular Therapy ·Gabriella Chirumbolo, Michele Dicataldo, Martina Barone, Gianluca Storci, Serena De Matteis, Noemi Laprovitera, Barbara Sinigaglia, Francesco Barbato, Enrico Maffini, Michèle Cavo, Francesca Bonifazi, Mario Arpinati	2023	3
5	Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells Clinical Cancer Research ·Giulia Corradi, Barbara Bassani, Giorgia Simonetti, Sabina Sangaletti, Jayakumar Vadakekolathu, Maria Chiara Fontana, Martina Pazzaglia, Alessandro Gulino, Claudio Tripodo, Gianluca Cristiano, Lorenza Bandini, Emanuela Ottaviani, Darina Očadlíková, Milena Piccioli, Giovanni Martinelli, Mario P. Colombo, Sergio Rutella, Michèle Cavo, Marilena Ciciarello, Antonio Curti	2022	35
6	Carfilzomib, Pomalidomide, and Dexamethasone As Second-line Therapy for Lenalidomide-refractory Multiple Myeloma HemaSphere ·Pieter Sonneveld, Sonja Zweegman, Michèle Cavo, Kazem Nasserinejad, Annemiek Broijl, Rosella Troia, Luděk Pour, Sandra Croockewit, Paolo Corradini, Francesca Patriarca, Kalung Wu, Jolanda Droogendijk, Gerard M.J. Bos, Roman Hájek, Maria Teresa Petrucci, Paula F. Ypma, Nicholas Zojer, Monique C. Minnema, Mario Boccadoro	2022	12
7	Isatuximab Plus Carfilzomib and Dexamethasone Versus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Patients Who Previously Underwent Transplantation: Ikema Subgroup Analysis Transplantation and Cellular Therapy ·Thomas G. Martin, Marcelo Capra, Mohamad Mohty, Kenshi Suzuki, Hang Quach, Michèle Cavo, Philippe Moreau, Meletios Α. Dimopoulos, Kwee Yong, Christina Tekle, Meredith C. Foster, Yvonne Barnes, Marie‐Laure Risse, Joseph Mıkhael	2021	2
8	Idecabtagene Vicleucel (ide-cel, bb2121) in Relapsed and Refractory Multiple Myeloma (RRMM): Analyses of High-Risk Subgroups in the KarMMa Study Transplantation and Cellular Therapy ·Noopur Raje, David S. Siegel, Sundar Jagannath, Sagar Lonial, Nikhil C. Munshi, Philippe Moreau, Hartmut Goldschmidt, Michèle Cavo, Anna Truppel-Hartmann, Everton Rowe, Liping Huang, Amit Agarwal, Julie Wang, Timothy Campbell, Jesús F. San Miguel, Donna Reece	2021	2
9	Efficacy and Safety of Idecabtagene Vicleucel (ide-cel, bb2121) in Elderly Patients with Relapsed and Refractory Multiple Myeloma: KarMMa Subgroup Analysis Transplantation and Cellular Therapy ·Jesús G. Berdeja, Noopur Raje, David S. Siegel, Yi Lin, Larry D. Anderson, Paula Rodríguez‐Otero, Salomon Manier, Hermann Einsele, Michèle Cavo, Anna Truppel-Hartmann, Everton Rowe, J P SANFORD, Julie Wang, Timothy Campbell, Sundar Jagannath	2021	2
10	Emerging Bone Marrow Microenvironment-Driven Mechanisms of Drug Resistance in Acute Myeloid Leukemia: Tangle or Chance? Cancers ·Marilena Ciciarello, Giulia Corradi, Dorian Forte, Michèle Cavo, Antonio Curti	2021	23
11	Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma Blood Advances ·Bachisio Ziccheddu, Giulia Biancon, Filippo Bagnoli, Chiara De Philippis, Francesco Maura, Even H Rustad, Matteo Dugo, Andrea Devecchi, Loris De Cecco, Marialuisa Sensi, Carolina Terragna, Marina Martello, Tina Bagratuni, Efstathios Kastritis, Meletios Α. Dimopoulos, Michèle Cavo, Cristiana Carniti, Vittorio Montefusco, Paolo Corradini, Niccolò Bolli	2020	49
12	Ceftolozane-Tazobactam Treatment of Hypervirulent Multidrug Resistant Pseudomonas aeruginosa Infections in Neutropenic Patients Microorganisms ·Paolo Elia Coppola, Paolo Gaibani, Chiara Sartor, Simone Ambretti, Russell E. Lewis, Claudia Sassi, Marco Pignatti, Stefania Paolini, Antonio Curti, Fausto Castagnetti, Margherita Ursi, Michèle Cavo, Marta Stanzani	2020	5
13	Disease-Specific Derangement of Circulating Endocannabinoids and N-Acylethanolamines in Myeloproliferative Neoplasms International Journal of Molecular Sciences ·Dorian Forte, Flaminia Fanelli, Marco Mezzullo, Martina Barone, Giulia Corradi, Giuseppe Auteri, Daniela Bartoletti, Marina Martello, Emanuela Ottaviani, Carolina Terragna, Antonio Curti, Uberto Pagotto, Francesca Palandri, Michèle Cavo, Lucia Catani	2020	5
14	Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis British Journal of Haematology ·Martina Barone, Francesca Ricci, Daria Sollazzo, Emanuela Ottaviani, Marco Romano, Giuseppe Auteri, Daniela Bartoletti, Maria Letizia Bacchi Reggiani, Nicola Vianelli, Pier Luigi Tazzari, Michèle Cavo, Dorian Forte, Francesca Palandri, Lucia Catani	2018	16
15	Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival Stem Cell Research & Therapy ·Giulia Corradi, Carmen Baldazzi, Darina Očadlíková, Giovanni Marconi, Sarah Parisi, Nicoletta Testoni, Carlo Finelli, Michèle Cavo, Antonio Curti, Marilena Ciciarello	2018	69
16	PET/CT Improves the Definition of Complete Response and Allows to Detect Otherwise Unidentifiable Skeletal Progression in Multiple Myeloma Clinical Cancer Research ·Elena Zamagni, Cristina Nanni, Katia Mancuso, Paola Tacchetti, Annalisa Pezzi, Lucia Pantani, Beatrice Anna Zannetti, Ilaria Rambaldi, Annamaria Brioli, Serena Rocchi, Carolina Terragna, Marina Martello, Giulia Marzocchi, Enrica Borsi, Ilaria Rizzello, Stefano Fanti, Michèle Cavo	2015	107
17	THE STRATUS (MM-010) TRIAL: A SINGLE-ARM, PHASE 3B STUDY EVALUATING SAFETY AND EFFICACY OF POMALIDOMIDE plus LOW-DOSE DEXAMETHASONE IN PATIENTS WITH REFRACTORY OR RELAPSED AND REFRACTORY MULTIPLE MYELOMA Haematologica ·Meletios Α. Dimopoulos, Antonio Palumbo, Paolo Corradini, Michèle Cavo, Michel Delforge, Katja Weisel, Enrique M. Ocio, Francesco Di Raimondo, Albert Oriol, Mathew Simcock, Neil Miller, Ana Slaughter, Teresa Peluso, Lars Sternås, Mohamed H. Zaki, Philippe Moreau	2015	1
18	Bortezomib-Based Versus Nonbortezomib-Based Induction Treatment Before Autologous Stem-Cell Transplantation in Patients With Previously Untreated Multiple Myeloma: A Meta-Analysis of Phase III Randomized, Controlled Trials Journal of Clinical Oncology ·Pieter Sonneveld, Hartmut Goldschmidt, Laura Rosiñol, Joan Bladé, Juan José Lahuerta, Michèle Cavo, Paola Tacchetti, Elena Zamagni, Michel Attal, Henk M. Lokhorst, Avinash Desai, Andrew Cakana, Kevin Liu, Helgi van de Velde, Dixie‐Lee Esseltine, Philippe Moreau	2013	150
19	Oral melphalan, prednisone, and thalidomide in elderly patients with multiple myeloma: updated results of a randomized controlled trial Blood ·Antonio Palumbo, Sara Bringhen, Anna Marina Liberati, Tommaso Caravita, Antonietta Falcone, Vincenzo Callea, Marco Montanaro, Roberto Ria, Antonio Capaldi, Renato Zambello, Giulia Benevolo, Daniele Derudas, Sylvain Doré, Federica Cavallo, Francesca Gay, Patrizia Falco, Giovannino Ciccone, Pellegrino Musto, Michèle Cavo, Mario Boccadoro	2008	250
20	Concomitant Mobilization of Plasma Cells and Hematopoietic Progenitors into Peripheral Blood of Patients with Multiple Myeloma Journal of Hematotherapy ·Roberto M. Lemoli, Michèle Cavo, Alessandra Fortuna	1996	19

About Michèle Cavo

Michèle Cavo is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Biological Psychiatry, having authored 557 papers that have together received 14.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (361 papers), Protein Degradation and Inhibitors (144 papers), Cancer Treatment and Pharmacology (88 papers), Peptidase Inhibition and Analysis (77 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (65 papers), Chronic Lymphocytic Leukemia Research (65 papers), Acute Myeloid Leukemia Research (54 papers) and Chronic Myeloid Leukemia Treatments (48 papers). The work is most often cited by research in Hematology (11.3k citations), Oncology (6.7k citations), Genetics (2.2k citations), Molecular Biology (7.7k citations) and Immunology (1.3k citations). Michèle Cavo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Elena Zamagni, S Tura, Jesús F. San Miguel, Paola Tacchetti, Michele Baccarani, Philippe Moreau, Patrizia Tosi, Pieter Sonneveld, Meletios Α. Dimopoulos and Thierry Façon. Their work appears in journals such as Blood, Journal of Clinical Oncology, European Journal Of Haematology, British Journal of Haematology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact